Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Autism

Recruiting now · Phase 1

Conditions studied: Autism

In brief

This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Autism

Key facts

Study ID

NCT05003960

Run by

The Foundation for Orthopaedics and Regenerative Medicine

People needed

15

Starts

2022-01-23

Expected to finish

2027-12-01

Last updated by the study team

2025-04-08

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Autism

You may not qualify if…

• Active infection
• Active cancer
• Chronic multisystem organ failure
• Pregnancy
• Clinically significant Abnormalities on pre-treatment laboratory evaluation
• Medical condition that would (based on the opinion of the investigator) compromise patient's safety
• Previous organ transplant
• Seizure disorder
• Hypersensitivity to sulfur

Where it is running

• Medical Surgical Associates Center — St John's, Antigua and Barbuda (enrolling)
• Athens Beverly Hills Medical Group — Glyfada, Athens, Greece (enrolling)
• Mediterraneo Hospital Ilias 8-12 — Glyfada, Athens, Greece (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.